vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $180.9M, roughly 1.6× AVANOS MEDICAL, INC.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -32.2%, a 31.5% gap on every dollar of revenue. On growth, Getty Images Holdings, Inc. posted the faster year-over-year revenue change (14.1% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $7.7M). Over the past eight quarters, Getty Images Holdings, Inc.'s revenue compounded faster (12.7% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
AVNS vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $282.3M |
| Net Profit | $-1.3M | $-90.9M |
| Gross Margin | 47.5% | 74.8% |
| Operating Margin | 1.4% | -8.5% |
| Net Margin | -0.7% | -32.2% |
| Revenue YoY | 0.7% | 14.1% |
| Net Profit YoY | 99.7% | -467.6% |
| EPS (diluted) | $-0.02 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $282.3M | ||
| Q3 25 | $177.8M | $240.0M | ||
| Q2 25 | $175.0M | $234.9M | ||
| Q1 25 | $167.5M | $224.1M | ||
| Q4 24 | $179.6M | $247.3M | ||
| Q3 24 | $170.4M | $240.5M | ||
| Q2 24 | $171.7M | $229.1M | ||
| Q1 24 | $166.1M | $222.3M |
| Q4 25 | $-1.3M | $-90.9M | ||
| Q3 25 | $-1.4M | $21.6M | ||
| Q2 25 | $-76.8M | $-34.4M | ||
| Q1 25 | $6.6M | $-102.6M | ||
| Q4 24 | $-397.3M | $24.7M | ||
| Q3 24 | $4.3M | $-2.5M | ||
| Q2 24 | $1.8M | $3.7M | ||
| Q1 24 | $-900.0K | $13.6M |
| Q4 25 | 47.5% | 74.8% | ||
| Q3 25 | 48.4% | 73.2% | ||
| Q2 25 | 52.6% | 72.1% | ||
| Q1 25 | 53.6% | 73.1% | ||
| Q4 24 | 54.6% | 73.5% | ||
| Q3 24 | 54.5% | 73.4% | ||
| Q2 24 | 55.7% | 72.5% | ||
| Q1 24 | 57.1% | 72.9% |
| Q4 25 | 1.4% | -8.5% | ||
| Q3 25 | 0.1% | 18.8% | ||
| Q2 25 | -42.6% | 15.1% | ||
| Q1 25 | 6.1% | 12.2% | ||
| Q4 24 | -233.0% | 14.5% | ||
| Q3 24 | 7.0% | 23.9% | ||
| Q2 24 | 3.7% | 20.3% | ||
| Q1 24 | 2.4% | 18.5% |
| Q4 25 | -0.7% | -32.2% | ||
| Q3 25 | -0.8% | 9.0% | ||
| Q2 25 | -43.9% | -14.6% | ||
| Q1 25 | 3.9% | -45.8% | ||
| Q4 24 | -221.2% | 10.0% | ||
| Q3 24 | 2.5% | -1.1% | ||
| Q2 24 | 1.0% | 1.6% | ||
| Q1 24 | -0.5% | 6.1% |
| Q4 25 | $-0.02 | $-0.22 | ||
| Q3 25 | $-0.03 | $0.05 | ||
| Q2 25 | $-1.66 | $-0.08 | ||
| Q1 25 | $0.14 | $-0.25 | ||
| Q4 24 | $-8.64 | $0.07 | ||
| Q3 24 | $0.09 | $-0.01 | ||
| Q2 24 | $0.04 | $0.01 | ||
| Q1 24 | $-0.02 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $90.2M |
| Total DebtLower is stronger | $90.3M | $1.3B |
| Stockholders' EquityBook value | $778.2M | $552.5M |
| Total Assets | $1.1B | $3.2B |
| Debt / EquityLower = less leverage | 0.12× | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $90.2M | ||
| Q3 25 | $70.5M | $109.5M | ||
| Q2 25 | $90.3M | $110.3M | ||
| Q1 25 | $97.0M | $114.6M | ||
| Q4 24 | $107.7M | $121.2M | ||
| Q3 24 | $89.0M | $109.9M | ||
| Q2 24 | $92.2M | $121.7M | ||
| Q1 24 | $75.8M | $134.2M |
| Q4 25 | $90.3M | $1.3B | ||
| Q3 25 | $93.4M | $1.3B | ||
| Q2 25 | $95.7M | $1.3B | ||
| Q1 25 | $98.0M | $1.3B | ||
| Q4 24 | $125.3M | $1.3B | ||
| Q3 24 | $152.6M | $1.3B | ||
| Q2 24 | $164.9M | $1.3B | ||
| Q1 24 | $167.2M | $1.4B |
| Q4 25 | $778.2M | $552.5M | ||
| Q3 25 | $778.0M | $634.6M | ||
| Q2 25 | $776.3M | $611.2M | ||
| Q1 25 | $839.4M | $593.0M | ||
| Q4 24 | $828.5M | $670.2M | ||
| Q3 24 | $1.2B | $683.4M | ||
| Q2 24 | $1.2B | $654.0M | ||
| Q1 24 | $1.2B | $640.8M |
| Q4 25 | $1.1B | $3.2B | ||
| Q3 25 | $1.1B | $2.6B | ||
| Q2 25 | $1.0B | $2.6B | ||
| Q1 25 | $1.1B | $2.6B | ||
| Q4 24 | $1.2B | $2.6B | ||
| Q3 24 | $1.7B | $2.6B | ||
| Q2 24 | $1.7B | $2.6B | ||
| Q1 24 | $1.7B | $2.6B |
| Q4 25 | 0.12× | 2.30× | ||
| Q3 25 | 0.12× | 2.11× | ||
| Q2 25 | 0.12× | 2.19× | ||
| Q1 25 | 0.12× | 2.21× | ||
| Q4 24 | 0.15× | 1.96× | ||
| Q3 24 | 0.12× | 1.97× | ||
| Q2 24 | 0.13× | 2.06× | ||
| Q1 24 | 0.14× | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $20.6M |
| Free Cash FlowOCF − Capex | $21.3M | $7.7M |
| FCF MarginFCF / Revenue | 11.8% | 2.7% |
| Capex IntensityCapex / Revenue | 3.8% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $20.6M | ||
| Q3 25 | $14.0M | $22.6M | ||
| Q2 25 | $6.8M | $6.5M | ||
| Q1 25 | $25.7M | $15.4M | ||
| Q4 24 | $57.9M | $39.7M | ||
| Q3 24 | $23.0M | $10.7M | ||
| Q2 24 | $27.8M | $46.4M | ||
| Q1 24 | $-8.0M | $21.5M |
| Q4 25 | $21.3M | $7.7M | ||
| Q3 25 | $7.0M | $7.9M | ||
| Q2 25 | $-4.2M | $-9.6M | ||
| Q1 25 | $19.0M | $-322.0K | ||
| Q4 24 | $53.1M | $24.6M | ||
| Q3 24 | $20.0M | $-1.8M | ||
| Q2 24 | $21.9M | $31.1M | ||
| Q1 24 | $-12.1M | $7.1M |
| Q4 25 | 11.8% | 2.7% | ||
| Q3 25 | 3.9% | 3.3% | ||
| Q2 25 | -2.4% | -4.1% | ||
| Q1 25 | 11.3% | -0.1% | ||
| Q4 24 | 29.6% | 9.9% | ||
| Q3 24 | 11.7% | -0.8% | ||
| Q2 24 | 12.8% | 13.6% | ||
| Q1 24 | -7.3% | 3.2% |
| Q4 25 | 3.8% | 4.6% | ||
| Q3 25 | 3.9% | 6.1% | ||
| Q2 25 | 6.3% | 6.9% | ||
| Q1 25 | 4.0% | 7.0% | ||
| Q4 24 | 2.7% | 6.1% | ||
| Q3 24 | 1.8% | 5.2% | ||
| Q2 24 | 3.4% | 6.7% | ||
| Q1 24 | 2.5% | 6.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | 1.61× | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | 12.59× | ||
| Q1 24 | — | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
